blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1412354

EP1412354 - DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A 2a? RECEPTOR AND THEIR USE AS MEDICAMENTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.03.2007
Database last updated on 11.05.2024
Most recent event   Tooltip05.10.2007Change - lapse in a contracting state
State(s) deleted from list of lapses: IT
published on 07.11.2007  [2007/45]
Applicant(s)For all designated states
SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A.
Viale Shakespeare, 47
00144 Roma / IT
[2006/19]
Former [2004/18]For all designated states
SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A.
Viale Shakespeare, 47
00144 Roma / IT
Inventor(s)01 / TARZIA, Giorgio, Sigma-Tau Ind. Farm. Riu. SpA
Via Pontina Km. 30,400
I-00040 Pomezia / IT
02 / PIERSANTI, Giovanni, Sigma-Tau Ind. Farm. Riu. SpA
Via Pontina Km. 30,400
I-00040 Pomezia / IT
03 / MINETTI, Patrizia, Sigma-Tau Ind. Farm. Riu. SpA
Via Pontina Km. 30,400
I-00040 Pomezia / IT
04 / DI CESARE, Maria A., Sigma-Tau Ind. Farm. Riu. SpA
Via Pontina Km. 30,400
I-00040 Pomezia / IT
05 / GALLO, Grazia, Sigma-Tau Ind. Farm. Riu. SpA
Via Pontina Km. 30,400
I-00040 Pomezia / IT
06 / GIORGI, Fabrizio, Sigma-Tau Ind. Farm. Riu. SpA
Via Pontina Km. 30,400
I-00040 Pomezia / IT
07 / GIORGI, Luca, Sigma-Tau Ind. Farm. Riu. SpA
Via Pontina Km. 30,400
I-00040 Pomezia / IT
 [2004/18]
Representative(s)Spadaro, Marco
Cavattoni-Raimondi
Viale dei Parioli 160
00197 Roma / IT
[N/P]
Former [2004/18]Spadaro, Marco
Cavattoni-Raimondi Viale dei Parioli 160
00197 Roma / IT
Application number, filing date02760555.925.07.2002
[2004/18]
WO2002IT00489
Priority number, dateIT2001RM0046531.07.2001         Original published format: IT RM20010465
[2004/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03011864
Date:13.02.2003
Language:EN
[2003/07]
Type: A1 Application with search report 
No.:EP1412354
Date:28.04.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 13.02.2003 takes the place of the publication of the European patent application.
[2004/18]
Type: B1 Patent specification 
No.:EP1412354
Date:10.05.2006
Language:EN
[2006/19]
Search report(s)International search report - published on:EP13.02.2003
ClassificationIPC:C07D473/34, C07D471/04, A61K31/435, A61K31/52, A61P25/00, A61P25/28, A61P25/16
[2004/18]
CPC data not yet available
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/18]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:DERIVATE VON TRIAZOLYL-IMIDAZOPYRIDINE UND VON TRIAZOLYLPURINE ALS LIGANDE DES ADENOSINE A2A REZEPTOREN UND IHRE VERWENDUNG ALS MEDICAMENTE[2004/18]
English:DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A 2a? RECEPTOR AND THEIR USE AS MEDICAMENTS[2004/18]
French:DERIVES DE TRIAZOLYL-IMIDAZOPYRIDINE ET DE TRIAZOLYLPURINES UTILISES EN TANT QUE LIGANDS DU RECEPTEUR DE L'ADENOSINE A2A ET LEUR UTILISATION EN TANT QUE MEDICAMENTS[2004/18]
Entry into regional phase20.01.2004National basic fee paid 
20.01.2004Designation fee(s) paid 
20.01.2004Examination fee paid 
Examination procedure23.01.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
20.01.2004Examination requested  [2004/18]
21.07.2004Despatch of a communication from the examining division (Time limit: M04)
15.11.2004Reply to a communication from the examining division
08.06.2005Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
16.06.2005Request for decision received: Application is deemed to be withdrawn
20.07.2005Fee for grant paid
20.07.2005Fee for publishing/printing paid
11.10.2005Communication of intention to grant the patent
11.10.2005Result of request for decision (Application is deemed to be withdrawn): Request accepted
Opposition(s)13.02.2007No opposition filed within time limit [2007/16]
Fees paidRenewal fee
21.06.2004Renewal fee patent year 03
17.06.2005Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  Tooltipdeleted
[2007/45]
Former [2007/39]IT10.05.2006
Cited inInternational search[A]WO9009178  (WHITBY RESEARCH INC [US]) [A] 1-31 * page 3 - page 6; example - *;
 [A]WO9606845  (DISCOVERY THERAPEUTICS INC [US]) [A] 1-31 * example - *;
 [A]EP1054012  (EISAI CO LTD [JP]) [A] 1-31 * claim - *;
 [AD]WO0102409  (VERNALIS RES LTD [GB], et al) [AD] 1-31 * example - *;
 [AD]  - YACOUBI ET AL., "SCH 58261 and ZM 241385 differentially prevent the motor effects of CGS 21680 in mice: evidence for a functional "atypical" adenosine A2a receptor", EUROPEAN JOURNAL OF PHARMACOLOGY, (2000), vol. 401, pages 63 - 77, XP002221553 [AD] 1-31 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0014-2999(00)00399-X
 [A]  - CAMAIONI E ET AL, "NEW SUBSTITUTED 9-ALKYLPURINES AS ADENOSINE RECEPTOR LIGANDS", BIOORGANIC & MEDICINAL CHEMISTRY, ELSEVIER SCIENCE LTD, GB, (1998), vol. 6, no. 5, ISSN 0968-0896, pages 523 - 533, XP002926121 [A] 1-31 * page 524 - page 525; tables 1,2 *

DOI:   http://dx.doi.org/10.1016/S0968-0896(98)00007-8
 [AD]  - ONGINI E ET AL, "Pharmacology of Adenosine A2A Receptors", TRENDS IN PHARMACOLOGICAL SCIENCES, ELSEVIER TRENDS JOURNAL, CAMBRIDGE, GB, (199610), vol. 17, no. 10, ISSN 0165-6147, pages 364 - 372, XP002123410 [AD] 1-31 * page 370 *

DOI:   http://dx.doi.org/10.1016/S0165-6147(96)10045-6
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.